Breaking News Instant updates and real-time market news.

WNS

WNS Holdings

$56.45

0.73 (1.31%)

06:14
04/25/19
04/25
06:14
04/25/19
06:14

WNS Holdings sees FY20 adjusted EPS $2-67-$2.90, consensus $2.81

Sees FY20 revenue less repair payments $854M-$900M, consensus $871.75M. Sees FY20 CapEx $37M.

  • 25

    Apr

  • 23

    May

WNS WNS Holdings
$56.45

0.73 (1.31%)

01/18/19
CANT
01/18/19
NO CHANGE
Target $61
CANT
Overweight
WNS Holdings price target raised to $61 from $56 at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph Foresi raised his price target for WNS Holdings to $61 saying the company yesterday reported "strong" fiscal Q3 results. Revenues were impacted by currency this quarter, but earnings "are well protected," Foresi tells investors in a post-earnings research note. He sees room for multiple expansion as the company continues to outperform expectations and keeps an Overweight rating on the shares.
01/28/19
LOOP
01/28/19
NO CHANGE
Target $65
LOOP
Buy
WNS Holdings' Denali addition yielding multiple benefits, says Loop Capital
Loop Capital analyst Joseph Vafi kept his Buy rating and $65 price target on WNS Holdings after his discussion with its head of sourcing practice, saying the company's Denali acquisition two years ago has yielded multiple benefits. The analyst points to the company's higher-growth, higher-margin revenue stream, decoupling revenue and headcount growth, differentiation in F&A function, and mutual cross-selling opportunities.
03/07/19
NEED
03/07/19
NO CHANGE
Target $65
NEED
Strong Buy
WNS Holdings price target raised to $65 from $60 at Needham
Needham analyst Mayank Tandon raised his price target on WNS Holdings to $65 after meeting with its SVP of Finance, saying the discussions suggest that the industry demand for Business Process Outsourcing industry remains solid. The analyst believes that the company's "deep vertical capabilities position it to continue to outperform its peers and sustain low double-digit organic growth. "
04/02/19
WEDB
04/02/19
NO CHANGE
Target $65
WEDB
Outperform
WNS Holdings price target raised to $65 from $55 at Wedbush
Wedbush analyst Moshe Katri raised his price target for WNS Holdings to $65 from $55 as he believes a combination of a robust pipeline, recent wins and reduced revenue headwinds will result in accelerated year over year revenue growth in FY20, above Street's current 10% growth projections. Relative to direct peers, WNS continues to generate superior growth rates, reflecting market's low penetration rates for BPO, as well as the company's differentiated approach to bundling analytics with its processing services, he contends. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

VZ

Verizon

$57.00

-1.01 (-1.74%)

08:26
06/27/19
06/27
08:26
06/27/19
08:26
Periodicals
Huawei in talks with Verizon over royalty payments for patents, CNBC reports »

Huawei is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 09

    Jul

  • 01

    Aug

DOVA

Dova Pharmaceuticals

$10.56

0.27 (2.62%)

08:25
06/27/19
06/27
08:25
06/27/19
08:25
Hot Stocks
Dova Pharmaceuticals announces FDA approval of sNDA for DOPTELET »

Dova Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 30

    Jun

WBC

Wabco

$131.95

-0.23 (-0.17%)

08:25
06/27/19
06/27
08:25
06/27/19
08:25
Conference/Events
Wabco to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

TSLA

Tesla

$219.22

-0.47 (-0.21%)

08:24
06/27/19
06/27
08:24
06/27/19
08:24
Initiation
Tesla initiated  »

Tesla initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

08:23
06/27/19
06/27
08:23
06/27/19
08:23
Hot Stocks
Ovid Therapeutics initiates Phase 3 trial of OV101 »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$22.20

0.35 (1.60%)

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Hot Stocks
Kratos Defense receives $4.1M C5ISR system contract award »

Kratos Defense &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRCA

Verrica Pharmaceuticals

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Recommendations
Verrica Pharmaceuticals analyst commentary  »

Verrica reported positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLPH

Delphi Technologies

$19.23

0.67 (3.61%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Initiation
Delphi Technologies initiated  »

Credit Suisse sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETTX

Entasis Therapeutics

$6.23

0.04 (0.65%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Hot Stocks
Entasis Therapeutics announces new results on antimicrobial programs »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$183.53

1.54 (0.85%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$77.84

0.82 (1.06%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$63.46

0.99 (1.58%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWA

BorgWarner

$41.55

0.05 (0.12%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Initiation
BorgWarner initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

XLY

Consumer Discretionary Sector SPDR

$118.12

0.35 (0.30%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$57.80

-0.12 (-0.21%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADAP

Adaptimmune

$4.07

0.07 (1.75%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Hot Stocks
Adaptimmune CFO Adrian Rawcliffe to succeed James Noble as CEO »

Adaptimmune Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BC

Brunswick

$45.29

0.2 (0.44%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Downgrade
Brunswick rating change  »

Brunswick downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$59.33

-1.3 (-2.14%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOVA

Dova Pharmaceuticals

$10.56

0.27 (2.62%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Conference/Events
Dova Pharmaceuticals to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

XLP

Consumer Staples Sector SPDR

$57.99

-0.82 (-1.39%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$91.62

-1.23 (-1.32%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$150.83

-0.31 (-0.21%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.